Pharma News India
The approval comes with a condition to divesting seven key products.
New Delhi, December 12, 2014: The Competition Commission of India (CCI) has given its approval to the Sun Pharma-Ranbaxy US$ 4 billion merger with a condition that they will have to modify the deal by divesting seven key products to address monopoly concerns.
The planned largest integrated pharmaceutical city in India is expected to be spread over 11,000 acres.
Hyderabad, December 4, 2014: Telangana plans to set up India's largest integrated pharmaceutical city with affluent plants and a township for employees. The government plans to attract investment of Rs 30,000 crore in phases.
The clause is expected to be included for the new clinical trials.
New Delhi, December 3, 2014: The Government of India plans to make quality accreditation mandatory for the new clinical trials taking place in the country by early next year. According to the recent reports, pharma companies or sponsors planning to conduct new clinical trials in India would require accreditation ...
The deal is a US$ 4 billion all-stock deal between Sun Pharma and Ranbaxy.
New Delhi, December 2, 2014: The Foreign Investment Promotion Board (FIPB) has given a green signal to the Sun Pharma acquisition of Ranbaxy. The deal is a US$ 4 billion all-stock deal between Sun Pharma and Ranbaxy and it sought the FIPB approval for issuing equity shared to non resident Indians in lieu o...
The company has launched the generic version of the Taxotere in the US market.
Hyderabad, November 25, 2014: Dr Reddy's Laboratories has launched the Docetaxel injection USP 20 mg/mL and 80 mg/4 mL, the generic version of the Taxotere in the US market.